Zevra Therapeutics(ZVRA)
$9.40+0.15 (+1.62%)
ZVRA
Zevra Therapeutics financials statements
$9.40
At close:+0.15 (+1.62%)
Want to see ZVRA full AI Analyst Report?
Zevra Therapeutics (ZVRA) Income Statement
1,159 Followers
Zevra Therapeutics Income Statement
Last quarter (Q3 2026), Zevra Therapeutics's total revenue was $37.76M, an increase of 44.86% from the same quarter last year. In Q3, Zevra Therapeutics's net income was $19.21M. See Zevra Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 106.47M | $ 23.61M | $ 27.46M | $ 10.16M | $ 28.65M | |
| $ 89.99M | $ 16.20M | $ 24.52M | $ 9.94M | $ 26.59M | |
| $ 94.22M | $ 103.20M | $ 74.12M | $ 52.50M | $ 18.86M | |
| Depreciation and Amortization | $ 4.05M | $ 6.39M | $ 1.01M | $ 944.00K | $ 257.00K |
| $ 98.71M | $ -76.40M | $ -43.54M | $ -25.53M | $ -7.89M | |
| $ -4.23M | $ -87.00M | $ -49.60M | $ -42.56M | $ 7.73M | |
| $ 90.91M | $ -3.14M | $ 3.56M | $ 15.76M | $ -16.25M | |
| $ 86.68M | $ -90.14M | $ -46.05M | $ -26.80M | $ -8.52M | |
| $ 83.23M | $ -105.51M | $ -46.05M | $ -26.77M | $ -8.55M | |
| Per Share Metrics | |||||
| Basic EPS | $ 1.40 | $ -2.28 | $ -1.30 | $ -0.78 | $ -2.11 |
| Diluted EPS | $ 1.35 | $ -2.28 | $ -1.30 | $ -0.78 | $ -2.11 |
| Weighted Average Shares Outstanding | 55.31M | 46.25M | 35.45M | 34.49M | 29.77M |
| Weighted Average Shares Outstanding (Diluted) | 57.26M | 46.25M | 35.45M | 34.49M | 29.77M |
Currency in USD

